To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Shortly after holding the second close on its debut fund at $150 million, the Chicago-based firm has acquired a disease management company in the firm’s second acquisition.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination